These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 28545010)

  • 1. Factors associated with response after deep transcranial magnetic stimulation in a real-world clinical setting: Results from the first 40 cases of treatment-resistant depression.
    Feffer K; Lapidus KAB; Braw Y; Bloch Y; Kron S; Netzer R; Nitzan U
    Eur Psychiatry; 2017 Jul; 44():61-67. PubMed ID: 28545010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial.
    Matsuda Y; Kito S; Igarashi Y; Shigeta M
    Neuropsychobiology; 2020; 79(3):208-213. PubMed ID: 31955155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.
    Berlim MT; Van den Eynde F; Tovar-Perdomo S; Chachamovich E; Zangen A; Turecki G
    World J Biol Psychiatry; 2014 Sep; 15(7):570-8. PubMed ID: 25050453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): a 6-month, open label, follow-up study.
    Rapinesi C; Curto M; Kotzalidis GD; Del Casale A; Serata D; Ferri VR; Di Pietro S; Scatena P; Bersani FS; Raccah RN; Digiacomantonio V; Ferracuti S; Bersani G; Zangen A; Angeletti G; Girardi P
    J Affect Disord; 2015 Mar; 174():57-63. PubMed ID: 25484178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex in depressive episodes of patients with major depressive disorder, bipolar disorder I, and major depressive with alcohol use disorders.
    Rapinesi C; Kotzalidis GD; Ferracuti S; Girardi N; Zangen A; Sani G; Raccah RN; Girardi P; Pompili M; Del Casale A;
    Neurosci Lett; 2018 Apr; 671():128-132. PubMed ID: 29454034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a pilot trial on five-factor prediction of antidepressant response.
    McGirr A; Van den Eynde F; Chachamovich E; Fleck MP; Berlim MT
    Neurosci Lett; 2014 Mar; 563():144-8. PubMed ID: 24486892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis.
    Kedzior KK; Gellersen HM; Brachetti AK; Berlim MT
    J Affect Disord; 2015 Nov; 187():73-83. PubMed ID: 26321258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of deep transcranial magnetic stimulation for treatment-resistant depression: A systematic review and meta-analysis.
    Hung YY; Yang LH; Stubbs B; Li DJ; Tseng PT; Yeh TC; Chen TY; Liang CS; Chu CS
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109850. PubMed ID: 31863873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-on deep transcranial magnetic stimulation (dTMS) in patients with dysthymic disorder comorbid with alcohol use disorder: a comparison with standard treatment.
    Girardi P; Rapinesi C; Chiarotti F; Kotzalidis GD; Piacentino D; Serata D; Del Casale A; Scatena P; Mascioli F; Raccah RN; Brugnoli R; Digiacomantonio V; Ferri VR; Ferracuti S; Zangen A; Angeletti G
    World J Biol Psychiatry; 2015 Jan; 16(1):66-73. PubMed ID: 25140585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
    Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
    J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
    Carpenter LL; Janicak PG; Aaronson ST; Boyadjis T; Brock DG; Cook IA; Dunner DL; Lanocha K; Solvason HB; Demitrack MA
    Depress Anxiety; 2012 Jul; 29(7):587-96. PubMed ID: 22689344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of deep transcranial magnetic stimulation on insomnia outcomes in patients with treatment-resistant depression: a retrospective study.
    Chopra A; Singal P; Kodya S
    J Clin Sleep Med; 2024 May; 20(5):813-815. PubMed ID: 38152858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural correlates of clinical improvement after deep transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a case report using functional magnetic resonance imaging.
    Harvey PO; Van den Eynde F; Zangen A; Berlim MT
    Neurocase; 2015 Feb; 21(1):16-22. PubMed ID: 24313336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: effectiveness and effects of age.
    Ciobanu C; Girard M; Marin B; Labrunie A; Malauzat D
    J Affect Disord; 2013 Sep; 150(2):677-81. PubMed ID: 23673085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
    Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
    World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients.
    Levkovitz Y; Harel EV; Roth Y; Braw Y; Most D; Katz LN; Sheer A; Gersner R; Zangen A
    Brain Stimul; 2009 Oct; 2(4):188-200. PubMed ID: 20633419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.